UPDATE : Thursday, August 6, 2020
상단여백
Genexine to start P1 trial of Covid-19 treatment in US by Lee Han-soo 2020-06-11 16:26
MSD Korea’s trade union refuses to use controversial monitoring program by Kim Yun-mi 2020-06-11 14:31
'Imfinzi changed treatment paradigm for non-resectable NSCLC' by Lee Han-soo 2020-06-10 17:58
‘Abbvie’s psoriasis drug proves long-term treatment effect’ by Shim Hyun-tai 2020-06-10 15:59
Baekje to distribute Leo Pharma's dermatology products by Lee Han-soo 2020-06-09 16:49
라인
LegoChem licenses in Covid-19 treatment candidates by Lee Han-soo 2020-06-09 16:48
MSD Korea’s privacy breach controversy resurfaces by Kim Yun-mi 2020-06-09 11:26
Korean, US firms in legal battle over Covid-19 vaccine know-how by Lee Han-soo 2020-06-08 21:28
Drug sales reps move briskly amid worries over Covid-19 resurge by Kim Yun-mi 2020-06-08 15:52
Kainos nears end of HIV drug’s clinical trials in China by Shim Hyun-tai 2020-06-05 17:40
라인
Rinvoq joins competition among JAK inhibitors by Kim Yun-mi 2020-06-05 16:16
IVI ties up with SNUH for clinical trial of Covid-19 vaccine by Lee Han-soo 2020-06-04 17:04
Huons’ dry eye drop scores German nod for clinical trial by Shim Hyun-tai 2020-06-04 16:25
MedPacto to test Vactosertib for treating NSCLC by Lee Han-soo 2020-06-04 12:43
Dupixent to provide new treatment options for asthma patients by Lee Han-soo 2020-06-03 17:54
라인
CDK 4/6 inhibitor market to heat up on insurance benefits by Lee Han-soo 2020-06-02 17:13
‘Keytruda doubled survival in advanced colon cancer compared to chemo’ by Kim Yun-mi 2020-06-02 11:27
Huons to supply emergency drugs to global market by Shim Hyun-tai 2020-06-01 15:26
'Lazertinib showed effect on lung cancer, brain metastasis' by Park Gi-taek 2020-06-01 14:08
Il-yang wins Russia’s nod to test potential Covid-19 drug in phase-3 study by Park Gi-taek 2020-05-29 16:57
여백
여백
여백
Back to Top